Searched for
RILUZOLE TABLETS
Are fundamental tailwinds a stronger play than volatile markets? 6 mid-cap pharma stocks with an upside potential of over 22%The Indian pharmaceutical sector has undergone significant changes over the past decade, marking a transition from a period of consolidatio...- Mid-cap pharma space: Risk & opportunity are two sides of the same coin. 7 pharma stocks with upside potential of up to 41%Two things increase the probability of a sector becoming the next big sector in India. One: As a country, India should have some edge in th...
- Volatile phases come and go, structural tailwinds are a stronger play: 5 Indian pharma stocks with upside potential of up to 35%There are some sectors which have witnessed something which can be called “second inning”. Which is that in the last two decades, they did ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 34%Given the way indices and broader markets have panned out, it is very likely that we are going to soon see the market hitting new highs. Th...
- After a long winter finally some tailwinds; 6 pharma stocks with upside potential of up to 31%While all pharma companies get classified into one sector they are very different at molecular level. Each company has its own operating ma...
- A Healthy Dose! 4 midcap pharma stocks with upside potential of up to 36%After a long period of under performance, pharma stocks have seen interest coming back from institutional investors. This is because some t...
- Finally out of the woods? 4 midcap pharma stocks with an upside potential up to 34 %Pharma stocks had been underperforming for a very long time. Some time USFDA issues, at other instances of pricing pressure in US markets h...
- On a path to recovery: 5 midcap pharma stocks with an upside potential up to 32%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in volatile markets. Some of them are mid-sized In...
- Midcaps with long term perspective; 9 stocks with high ROE & net profit marginMany investors, especially the ones sitting on cash are confused about what they should do with their existing stocks – buy the dip or not....
- USFDA gives nod for Riluzole tablets to Sun Pharma, GlenmarkSun Pharma and Glenmark have got approval from US health regulator to sell generic versions of nervous system disorder treatment drug Riluz...
- Sensex tanks 400 points; top ten stocks in actionSensex nosedived over 400 points and slipped below 19000 levels. Take a look at ten stocks which are in focus in morning trade.
- Ten stocks in focus in Thursday morning tradeIndian markets are likely to trade in a range. Here is a list of ten stocks which are likely to remain in focus in morning trade.
- Glenmark gets USFDA approval for sclerosis treatment drugDrug firm Glenmark Pharmaceuticals today said it has received US health regulator's approval to market Riluzole tablets.
- Sun Pharma drug gets US nodSun Pharma on Tuesday said it has received tentative approval from US health regulator to sell a generic version of Rilutek tablets.
Load More
